Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Genomics Market, by Product & Service
1.4.2 North America Genomics Market, by Application
1.4.3 North America Genomics Market, by End User
1.4.4 North America Genomics Market, by Technology
1.4.5 North America Genomics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2017, Jan – 2021, Dec) Leading Players
Chapter 4. North America Genomics Market by Product & Service
4.1 North America Consumables Market by Country
4.2 North America Systems & Software Market by Country
4.3 North America Services Market by Country
Chapter 5. North America Genomics Market by Application
5.1 North America Drug Discovery & Development Market by Country
5.2 North America Diagnostics Market by Country
5.3 North America Agriculture & Animal Research Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Genomics Market by End User
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Research Centers and Academic & Government Institutes Market by Country
6.3 North America Pharmaceutical & Biotechnology Companies Market by Country
6.4 North America Others Market by Country
Chapter 7. North America Genomics Market by Technology
7.1 North America Sequencing Market by Country
7.2 North America PCR Market by Country
7.3 North America Nucleic Acid Extraction & Purification Market by Country
7.4 North America Microarray Market by Country
7.5 North America Others Market by Country
Chapter 8. North America Genomics Market by Country
8.1 US Genomics Market
8.1.1 US Genomics Market by Product & Service
8.1.2 US Genomics Market by Application
8.1.3 US Genomics Market by End User
8.1.4 US Genomics Market by Technology
8.2 Canada Genomics Market
8.2.1 Canada Genomics Market by Product & Service
8.2.2 Canada Genomics Market by Application
8.2.3 Canada Genomics Market by End User
8.2.4 Canada Genomics Market by Technology
8.3 Mexico Genomics Market
8.3.1 Mexico Genomics Market by Product & Service
8.3.2 Mexico Genomics Market by Application
8.3.3 Mexico Genomics Market by End User
8.3.4 Mexico Genomics Market by Technology
8.4 Rest of North America Genomics Market
8.4.1 Rest of North America Genomics Market by Product & Service
8.4.2 Rest of North America Genomics Market by Application
8.4.3 Rest of North America Genomics Market by End User
8.4.4 Rest of North America Genomics Market by Technology
Chapter 9. Company Profiles
9.1 Creative Biogene
9.1.1 Company Overview
9.2 Thermo Fisher Scientific, Inc.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.6 SWOT Analysis
9.3 Illumina, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Acquisition and Mergers:
9.4 Bio-Rad laboratories, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.5.2 Product Launches and Product Expansions:
9.4.5.3 Acquisition and Mergers:
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.5.3 Acquisition and Mergers:
9.7 F. Hoffmann-La Roche Ltd.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Product Launches and Product Expansions:
9.7.5.3 Acquisition and Mergers:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.5.3 Acquisition and Mergers:
9.10. New England BioLabs, Inc.
9.10.1 Company Overview
9.10.2 Recent strategies and developments:
9.10.2.1 Product Launches and Product Expansions: